Impact of Enhanced Information on Subjective Information Level and PROMs in Patients with Aortic Stenosis

NCT06706635 · tracked via the Priya Life Science Germany tracker

Sponsor

Heart and Diabetes Center North-Rhine Westfalia

Phase

Not applicable

Started

2024-08-21

Last updated

2024-11-26

Condition(s) studied

Aortic Stenosis Disease

Investigational drug(s) / intervention(s)

Application of App

Application of App: Full Access to Mobile App

Study summary

The aim of this trial is to evaluate if an enhanced information by using a mobile App can increase subjective information level in patients with severe aortic stenosis and may therefore improve patient-reported outcomes.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * severe aortic valve stenosis * planned aortic valve replacement (TAVI) * Patient is willing and able to complete the surveys in German language * Written informed consent by the trial subject Exclusion Criteria: \- Language barrier

Primary outcome measure(s)

Subjective information level (EORTC QOL-INFO 25 questionnaire) — From enrollment to the end of FU at 3 months

Trial sites (1)

Facility	City	Region	Status
Clinic for General and Interventional Cardiology/Angiology, Herz- und Diabeteszentrum NRW	Bad Oeynhausen	Germany	Recruiting

More Heart and Diabetes Center North-Rhine Westfalia trials in Germany

Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis Recruiting

Gender-specific Evaluation of Symptom Awareness in Female Versus Male Patients with Severe Aortic Stenosis Active, not recruiting

CT Prediction for Transcatheter Tricuspid Interventions Recruiting

Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06706635 on ClinicalTrials.gov ↗ ← All trials in Germany